Galectin Therapeutics logo
Galectin Therapeutics
GALT | NASDAQ
Chart Builder DCF Calculator
$3.02
-$0.03 (-0.98%)
At close: Nov 16, 2026, 4:00 PM ET
$3.02
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Galectin Therapeutics Cash Flow Statement

Cash flow statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
-30.84M -47.05M -41.07M -38.78M -30.53M -23.47M
53K 37K 33K 32K 41K 36K
1.66M 2.45M 2.26M 2.87M 2.08M 1.8M
6.65M 4.36M 2.01M 724K 65K -1.59M
4.64M 512K 1.13M -147K 351K 87K
– – – – – –
609K 2.28M 4.68M 4.97M 3.75M 942K
-23.88M -41.77M -32.97M -31.06M -24.31M -20.6M
– – – – – –
– – – – – –
– – – – – –
– – – – – –
– – – – – –
– – – – – –
21M 30M 30M 10M 30M –
– – – – – –
– -91K – – -171K -137K
– 91K 10.03M – 171K 137K
26.48M 31.23M 40.03M 10M 36.81M 263K
2.6M -10.54M 7.07M -21.06M 12.51M -20.34M
-23.88M -41.77M -32.97M -31.06M -24.31M -20.6M
-25.53M -44.21M -35.23M -33.92M -26.38M -22.4M
– – – – – –
– – – – – –
-23.88M -41.77M -32.97M -31.06M -24.31M -20.6M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.